294 related articles for article (PubMed ID: 26718891)
21. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of LN-308 glioma cell proliferation and migration by retinoic acid amide through activation of Akt pathway.
Zhu J; Lu XD; Si F; Song CY; Meng QH
Int J Clin Exp Pathol; 2015; 8(11):13921-7. PubMed ID: 26823704
[TBL] [Abstract][Full Text] [Related]
23. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
24. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
25. Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells.
Sun L; Li G; Dai B; Tan W; Zhao H; Li X; Wang A
Mol Med Rep; 2015 Sep; 12(3):3423-3431. PubMed ID: 26043756
[TBL] [Abstract][Full Text] [Related]
26. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
27. [The anti-cancer effect of ZR30 protein via targeting extracellular signal proteins of different cell subpopulations of glioma].
Li YY; Chen XH; Sun T; Hu Y; Zhou YH; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):812-817. PubMed ID: 30481930
[No Abstract] [Full Text] [Related]
28. Decreased TIP30 expression promotes tumor metastasis in lung cancer.
Tong X; Li K; Luo Z; Lu B; Liu X; Wang T; Pang M; Liang B; Tan M; Wu M; Zhao J; Guo Y
Am J Pathol; 2009 May; 174(5):1931-9. PubMed ID: 19349353
[TBL] [Abstract][Full Text] [Related]
29. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
30. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
31. Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B rhoGAP.
Kwak SY; Yang JS; Kim BY; Bae IH; Han YH
Biochim Biophys Acta; 2014 Mar; 1843(3):508-16. PubMed ID: 24316134
[TBL] [Abstract][Full Text] [Related]
32. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
Li X; Ling N; Bai Y; Dong W; Hui GZ; Liu D; Zhao J; Hu J
Anat Rec (Hoboken); 2013 Mar; 296(3):427-32. PubMed ID: 23175429
[TBL] [Abstract][Full Text] [Related]
33. GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway.
Wang Z; Yuan H; Sun C; Xu L; Chen Y; Zhu Q; Zhao H; Huang Q; Dong J; Lan Q
Med Oncol; 2015 Apr; 32(4):87. PubMed ID: 25707769
[TBL] [Abstract][Full Text] [Related]
34. A role for LRIG1 in the regulation of malignant glioma aggressiveness.
Mao F; Wang B; Xiao Q; Xi G; Sun W; Zhang H; Ye F; Wan F; Guo D; Lei T; Chen X
Int J Oncol; 2013 Mar; 42(3):1081-7. PubMed ID: 23337938
[TBL] [Abstract][Full Text] [Related]
35. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
[TBL] [Abstract][Full Text] [Related]
36. Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
Du W; Pang C; Wang D; Zhang Q; Xue Y; Jiao H; Zhan L; Ma Q; Wei X
PLoS One; 2015; 10(5):e0127976. PubMed ID: 26011451
[TBL] [Abstract][Full Text] [Related]
37. An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.
Kang CS; Pu PY; Li YH; Zhang ZY; Qiu MZ; Huang Q; Wang GX
J Neurooncol; 2005 Sep; 74(3):267-73. PubMed ID: 16132520
[TBL] [Abstract][Full Text] [Related]
38. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
39. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy using Notch and Akt inhibitors is effective for suppressing invasion but not proliferation in glioma cells.
Jin R; Nakada M; Teng L; Furuta T; Sabit H; Hayashi Y; Demuth T; Hirao A; Sato H; Zhao G; Hamada J
Neurosci Lett; 2013 Feb; 534():316-21. PubMed ID: 23262078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
